Your browser doesn't support javascript.
Conditionality of COVID-19 vaccine acceptance in European countries.
Heyerdahl, Leonardo W; Vray, Muriel; Lana, Benedetta; Tvardik, Nastassia; Gobat, Nina; Wanat, Marta; Tonkin-Crine, Sarah; Anthierens, Sibyl; Goossens, Herman; Giles-Vernick, Tamara.
  • Heyerdahl LW; Anthropology & Ecology of Disease Emergence Unit, Institut Pasteur, 25-28 rue du Dr Roux, 75015 Paris, France.
  • Vray M; Emerging Diseases Epidemiology Unit, Institut Pasteur, 25-28 rue du Dr Roux, 75015 Paris, France.
  • Lana B; Anthropology & Ecology of Disease Emergence Unit, Institut Pasteur, 25-28 rue du Dr Roux, 75015 Paris, France.
  • Tvardik N; Anthropology & Ecology of Disease Emergence Unit, Institut Pasteur, 25-28 rue du Dr Roux, 75015 Paris, France.
  • Gobat N; Nuffield Department of Primary Care Health Sciences, University of Oxford Radcliffe Primary Care Building, Radcliffe Observatory Quarter, Oxford, UK.
  • Wanat M; Nuffield Department of Primary Care Health Sciences, University of Oxford Radcliffe Primary Care Building, Radcliffe Observatory Quarter, Oxford, UK.
  • Tonkin-Crine S; Nuffield Department of Primary Care Health Sciences, University of Oxford Radcliffe Primary Care Building, Radcliffe Observatory Quarter, Oxford, UK.
  • Anthierens S; Department of Family Medicine and Population Health, University of Antwerp, Gouverneur Kinsbergen, Doornstraat 331, 2610 Wilrijk, Belgium.
  • Goossens H; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium.
  • Giles-Vernick T; Anthropology & Ecology of Disease Emergence Unit, Institut Pasteur, 25-28 rue du Dr Roux, 75015 Paris, France. Electronic address: tamara.giles-vernick@pasteur.fr.
Vaccine ; 40(9): 1191-1197, 2022 02 23.
Article in English | MEDLINE | ID: covidwho-1757898
ABSTRACT
The COVID-19 vaccine rollout has offered a powerful preventive measure to help control SARS-CoV-2 transmission. Nevertheless, long-standing public hesitation around vaccines heightened concerns that vaccine coverage would not achieve desired public health impacts, particularly in light of more contagious variants. This cross-sectional survey was conducted online just before the European vaccine rollout in December 2020 among 7000 respondents (aged 18-65) in Belgium, France, Germany, Italy, Spain, Sweden, and Ukraine. The survey included open text boxes for fuller explanation of responses. Overall, 56.9% of respondents would accept a COVID-19 vaccine, 19.0% would not, and 24.1% did not know or preferred not to say. By country, between 44% (France) and 66% (Italy) of respondents would accept a COVID-19 vaccine. Respondents expressed conditionality in open responses, voicing concerns about vaccine safety and mistrust of authorities. We highlight lessons learned about the dynamism of vaccine conditionality and persistence of safety concerns.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Observational study / Randomized controlled trials Topics: Vaccines / Variants Limits: Adolescent / Adult / Aged / Humans / Middle aged / Young adult Language: English Journal: Vaccine Year: 2022 Document Type: Article Affiliation country: J.vaccine.2022.01.054

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Observational study / Randomized controlled trials Topics: Vaccines / Variants Limits: Adolescent / Adult / Aged / Humans / Middle aged / Young adult Language: English Journal: Vaccine Year: 2022 Document Type: Article Affiliation country: J.vaccine.2022.01.054